Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/10/2011 | US20110277089 Plants and seeds of hybrid corn variety ch727695 |
11/10/2011 | US20110277088 Plants and seeds of hybrid corn variety ch848055 |
11/10/2011 | US20110277087 Plants and seeds of hybrid corn variety ch091754 |
11/10/2011 | US20110277086 Plants and seeds of hybrid corn variety ch422303 |
11/10/2011 | US20110277085 Plants and seeds of hybrid corn variety ch752576 |
11/10/2011 | US20110277084 Plants and seeds of corn variety cv352638 |
11/10/2011 | US20110277083 Plants and seeds of corn variety cv258468 |
11/10/2011 | US20110277082 Plants and seeds of corn variety cv182075 |
11/10/2011 | US20110277081 Plants and seeds of corn variety cv379998 |
11/10/2011 | US20110277080 Plants and seeds of corn variety cv577598 |
11/10/2011 | US20110277079 Plants and seeds of corn variety cv669244 |
11/10/2011 | US20110277078 Plants and seeds of corn variety cv408816 |
11/10/2011 | US20110277077 Plants and seeds of hybrid corn variety ch409218 |
11/10/2011 | US20110277076 Plants and seeds of hybrid corn variety ch000359 |
11/10/2011 | US20110277075 Plants and seeds of hybrid corn variety ch683282 |
11/10/2011 | US20110277074 Plants and seeds of hybrid corn variety ch006642 |
11/10/2011 | US20110277073 Plants and seeds of hybrid corn variety ch700775 |
11/10/2011 | US20110277072 Plants and seeds of hybrid corn variety ch861515 |
11/10/2011 | US20110277071 Plants and seeds of hybrid corn variety ch594228 |
11/10/2011 | US20110277070 Plants and seeds of hybrid corn variety ch113132 |
11/10/2011 | US20110277069 Plants and seeds of hybrid corn variety ch970892 |
11/10/2011 | US20110277068 Plants and seeds of corn variety cv480351 |
11/10/2011 | US20110277067 Plants and seeds of corn variety cv295879 |
11/10/2011 | US20110277066 Plants and seeds of corn variety cv378013 |
11/10/2011 | US20110277065 Plants and seeds of corn variety cv599033 |
11/10/2011 | US20110277064 Plants and seeds of corn variety cv397769 |
11/10/2011 | US20110277048 Transgenic Aves Producing Human Polyclonal Antibodies |
11/10/2011 | US20110277045 Methods for increasing beta cell mass comprising administering a ra770 polypeptide |
11/10/2011 | US20110275792 Metal coordinated compositions |
11/10/2011 | US20110275788 Fibrous protein fusions and use thereof in the formation of advanced organic/inorganic composite materials |
11/10/2011 | US20110275787 Cross-species-specific single domain bispecific single chain antibody |
11/10/2011 | US20110275575 Peptide inhibitors of protein kinase c |
11/10/2011 | US20110275573 Tissue adhesive |
11/10/2011 | US20110275569 Proteases targeting agents |
11/10/2011 | US20110275564 Erythropoietin |
11/10/2011 | US20110275563 Use of CTGF as a Cardioprotectant |
11/10/2011 | US20110275560 Synthetic conjugates and uses thereof |
11/10/2011 | US20110275559 Long-Acting Y2 and/or Y4 Receptor Agonists |
11/10/2011 | US20110275557 TRUNCATED Cry35 PROTEINS |
11/10/2011 | US20110275541 Use of multiple recombination sites with unique specificity in combinational cloning |
11/10/2011 | US20110275150 Compstatin analogs with improved activity |
11/10/2011 | US20110275146 Fusion proteins comprising dp-178 and other viral fusion inhibitor peptides useful for treating aids |
11/10/2011 | US20110275135 Genetic elements, proteins, and associated methods including application of additional genetic information to gram (+) thermoacidophiles |
11/10/2011 | US20110275132 Purification of bacterial antigens |
11/10/2011 | US20110275120 Fusion Proteins With Cleavable Spacers and Uses Thereof |
11/10/2011 | US20110275107 Long wavelength engineered fluorescent proteins |
11/10/2011 | US20110275102 Activation of mutated rac-pk |
11/10/2011 | US20110275093 Novel use of adenoviruses and nucleic acids that code for said viruses |
11/10/2011 | US20110275073 Method for detecting tumor-associated DNA in blood or blood fractions |
11/10/2011 | US20110274797 Production of soluble protein solutions from pulses |
11/10/2011 | US20110274749 Methods and compositions for targeting agents into and across the blood-brain barrier and other endothelial cell microvascular barriers |
11/10/2011 | US20110274721 Hiv vaccines based on env of multiple clades of hiv |
11/10/2011 | US20110274720 Capsular gram-positive bacteria bioconjugate vaccines |
11/10/2011 | US20110274710 Pcv2 immunogenic compositions and methods of producing such compositions |
11/10/2011 | US20110274709 T-Cell Immunogens Derived from Anti-Viral Proteins and Methods of Using Same |
11/10/2011 | US20110274708 Short-form human md-2 as a negative regulator of toll-like receptor 4 signaling |
11/10/2011 | US20110274707 Composition for improving inflammatory disease using abh antigens |
11/10/2011 | US20110274693 Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof |
11/10/2011 | US20110274690 Compositions and methods for the diagnosis and treatment of tumor |
11/10/2011 | US20110274675 Therapeutically Useful Molecules |
11/10/2011 | US20110274650 Compositions and methods of treating inflammatory and autoimmune diseases |
11/10/2011 | US20110274623 Stabilized Fibronectin Domain Compositions, Methods and Uses |
11/10/2011 | DE102010019336A1 Mittel zur Behandlung der Alzheimerschen Demenz Agents for the treatment of Alzheimer's dementia |
11/10/2011 | CA2805267A1 Detection and treatment of fibrosis |
11/10/2011 | CA2798764A1 Genetic signatures in hiv-1 subtype c envelope glycoproteins |
11/10/2011 | CA2798139A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex |
11/10/2011 | CA2797842A1 Immunogenic compositions and methods for treating neoplasia |
11/09/2011 | EP2385132A1 Multimeric ligands with enhanced stability |
11/09/2011 | EP2385127A1 Chimeric, hybrid and tandem polypeptides of meningococcal NMB1870 |
11/09/2011 | EP2385126A1 Chimeric, hybrid and tandem polypeptides of meningococcal NMB1870 |
11/09/2011 | EP2385124A2 Peptides or peptide analogues for modulating the binding of a PDZ protein and a PL protein |
11/09/2011 | EP2385121A1 Antagonists of Sema3E/PlexinD1 interaction as anti-cancer agents |
11/09/2011 | EP2385118A1 In vitro peptide expression library |
11/09/2011 | EP2385117A1 HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same |
11/09/2011 | EP2385116A1 Nucleic acid derived from hepatitis c virus, and expression vector, transformed cell and hepatitis c virus particles each prepared by using same |
11/09/2011 | EP2385110A2 Methods for enhancing the degradation or conversion of cellulosic material |
11/09/2011 | EP2385107A1 Lentiviral vector based immunological compounds against malaria |
11/09/2011 | EP2385071A1 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1 |
11/09/2011 | EP2385067A1 Artificial antibody polypeptides |
11/09/2011 | EP2385066A1 Recombinant MHC Molecules Useful for Manipulation of Antigen-Specific T Cells |
11/09/2011 | EP2385065A1 Immunosuppressive polypeptides and nucleic acids |
11/09/2011 | EP2385064A2 Agents disrupting a growth factor complex |
11/09/2011 | EP2385063A2 Growth factor complex |
11/09/2011 | EP2385062A2 Methods and compositions for treating prostate cancer or inducing a humoral immune response against prostate cancer |
11/09/2011 | EP2385061A2 Neuritogenic peptides |
11/09/2011 | EP2385060A2 Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma |
11/09/2011 | EP2385059A2 Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma |
11/09/2011 | EP2385058A1 Method for detecting the expression of a human endogenous retrovirus envelope protein and uses of a coding gene for said protein |
11/09/2011 | EP2385056A2 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
11/09/2011 | EP2384764A2 Compositions and methods for modulating hemostasis using variant forms of activated factor V |
11/09/2011 | EP2384763A1 A peptide ligand to impair cancer cell migration |
11/09/2011 | EP2384760A1 Sulphated hyaluronic acid in combination with G-CSF for use in mobilising blood stem cells |
11/09/2011 | EP2384759A1 Sulphated hyaluronic acid in combination with G-CSF for use in mobilising blood stem cells |
11/09/2011 | EP2384441A1 Isolated peptides of rabbit factor vii |
11/09/2011 | EP2384440A1 Synthetic peptides, methods and kits for diagnosing autoimmune diseases |
11/09/2011 | EP2384338A2 Glp-1 analogs and uses thereof |
11/09/2011 | EP2384337A1 Means and method for the treatment of antibody deficiency diseases based on il-21 and il-21 variants |
11/09/2011 | EP2384336A1 A variant of mite allergen and uses thereof |
11/09/2011 | EP2384335A1 Biosurfactant composition produced by a new bacillus licheniformis strain, uses and products thereof |
11/09/2011 | EP2384329A1 Novel fluorescent boron-substituted dipyrromethenes and use thereof for diagnosis |